Syngene International Limited

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40009005

Informations générales

Localisation

India

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

10/10/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2033

Statut

Targets set

Classification

1.5°C

Année cible

FY2033

Progression vers l'objectif0%
2015 (année de référence)FY2033
Description complète des objectifs

Syngene International Limited commits to reduce absolute scope 1 and 2 GHG emissions 54.6% by FY2033 from a FY2023 base year. Syngene International Limited commits that 81.6% of its suppliers by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution will have science-based targets by FY2028.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

INE398R01022

Source : Science Based Targets initiative | Données publiques